Company Erin Resources Ltd Australian S.E.

Company Erin Resources Ltd Australian S.E.

AU000000ERI2

Pharmaceuticals

Equities

AU000000ERI2

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Sector Alternative Medicine

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Sector Alternative Medicine

Inactive Instrument

End-of-day quote Australian S.E. Other stock markets
- ^AUD	-

05-07	Argent BioPharma Reports CFO Appointment	MT
05-07	Argent BioPharma shares begin trading on OTCQB Venture Market	AN

Argent BioPharma Ltd, formerly MGC Pharmaceuticals Ltd, is an Australia-based drug discovery company. The Company is focused on developing and supplying accessible and ethically produced plant-derived medicines, combining in-house research with technologies. Its approach combines in-house research with technology, all discovering and producing treatments for unmet medical conditions. Its investigational medicinal (IMPs) products include CannEpil, CimetrA and CogniCann. CimetrA is a phyto medicine based on natural ingredients from Curcumin and Boswellia serrata, delivered in the nanoparticle delivery system, which is being developed for acute lung injury and acute respiratory distress syndrome (ARDS). CannEpil is a phyto medicine based on phytocannabinoid is being developed for the treatment of refractory epilepsy and cerebral palsy. CogniCann is a phyto medicine based on phytocannabinoids is in investigation stage as a treatment for the symptoms associated with dementia and Alzheimer.

AUD in Million	2022	Weight	2023	Weight	Delta
Cannabinoids 74.0 %	4	85.1 %	3	74.0 %	-37.74%
Non-pharma 25.8 %	0	4.8 %	1	25.8 %	+282.89%
Consulting Services 0.2 %	0	10.1 %	0	0.2 %	-98.54%

AUD in Million	2022	Weight	2023	Weight	Delta
Slovenia 84.0 %	3	68.0 %	3	84.0 %	-11.58%
Australia and Others 15.8 %	1	22.3 %	1	15.8 %	-49.46%
Israel 0.2 %	0	9.6 %	0	0.2 %	-98.45%

Managers	Title	Age	Since
Roby Zomer FOU	Founder	44	20/10/05
Yifat Steuer COO	Chief Operating Officer	53	03/10/22
Nadya Lisovoder CTO	Chief Tech/Sci/R&D Officer	-	-
Rowan Harland SEC	Corporate Secretary	-	28/02/23
Robert Clements PRN	Corporate Officer/Principal	-	18/07/22
Sabina SuljakoviÄ‡ PRN	Corporate Officer/Principal	-	30/11/20
Amir Polak PRN	Corporate Officer/Principal	-	31/08/20

Members of the board	Title	Age	Since
Roby Zomer FOU	Founder	44	20/10/05
Layton Patrick Mills BRD	Director/Board Member	-	31/05/23
Daniel Robinson BRD	Director/Board Member	-	11-30

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	36,491,631	3,446,355 ( 9.444 %)	0	9.444 %

Name	Equities	%	Valuation
SpreadEx Ltd. 2.195 %	993,953	2.195 %	264 620 $
Premier Fund Managers Ltd. 0.3891 %	176,203	0.3891 %	46 911 $
Chelverton Asset Management Ltd. 0.2208 %	100,000	0.2208 %	26 623 $
Brett Mitchell 0.0684 %	30,961	0.0684 %	8 243 $
Evolve Funds Group, Inc. 0.000669 %	303	0.000669 %	81 $
Evan Hayes 0.000651 %	295	0.000651 %	79 $

MGC Pharmaceuticals Ltd.

295 Rokeby Road Suite 1

6008, Subiaco

+61 8 6555 2950

http://www.mgcpharma.com.au

	1st Jan change	Capi.
DONG-E-E-JIAO CO.,LTD.	+37.29%	6.02B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-21.28%	4.19B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+4.52%	3.25B
TASLY PHARMACEUTICAL GROUP CO., LTD	-18.16%	2.87B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-7.70%	2.37B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+41.50%	1.89B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-4.05%	1.58B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-15.56%	1.54B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-14.62%	1.5B

Alternative Medicine

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Alternative Medicine